U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H7ClN2O2S
Molecular Weight 230.671
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIAZOXIDE

SMILES

CC1=NC2=C(C=C(Cl)C=C2)S(=O)(=O)N1

InChI

InChIKey=GDLBFKVLRPITMI-UHFFFAOYSA-N
InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11)

HIDE SMILES / InChI
Molecular Formula C8H7ClN2O2S
Molecular Weight 230.671
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:12:49 UTC 2023
Edited
by admin
on Fri Dec 15 15:12:49 UTC 2023
Record UNII
O5CB12L4FN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIAZOXIDE
EP   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
USAN   INN  
Official Name English
EUDEMINE INJECTION
Common Name English
DIAZOXIDE [EP MONOGRAPH]
Common Name English
7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
Systematic Name English
DIAZOXIDE [MI]
Common Name English
SCH-6783
Code English
DIAZOXIDE [ORANGE BOOK]
Common Name English
SCH 6783
Code English
Diazoxide [WHO-DD]
Common Name English
HYPERSTAT
Brand Name English
DIAZOXIDE [VANDF]
Common Name English
DIAZOXIDE [USP-RS]
Common Name English
DIAZOXIDE [USP MONOGRAPH]
Common Name English
2H-1,2,4-BENZOTHIADIAZINE, 7-CHLORO-3-METHYL-, 1,1-DIOXIDE
Systematic Name English
HYPERTONALUM
Common Name English
DIAZOXIDE [MART.]
Common Name English
DIAZOXIDE [JAN]
Common Name English
PROGLYCEM
Brand Name English
diazoxide [INN]
Common Name English
DIAZOXIDUM [WHO-IP LATIN]
Common Name English
SRG-95213
Code English
SRG 95213
Code English
NSC-76130
Code English
DIAZOXIDE [WHO-IP]
Common Name English
DIAZOXIDE [USAN]
Common Name English
NSC-64198
Code English
Classification Tree Code System Code
WHO-ATC V03AH01
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
WHO-ATC C02DA01
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
NCI_THESAURUS C29707
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
WHO-VATC QV03AH01
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
WHO-VATC QC02DA01
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
FDA ORPHAN DRUG 383712
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
Code System Code Type Description
MERCK INDEX
m4277
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID7022914
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
DIAZOXIDE
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY Description: A white, or almost white, crystalline powder; odourless. Solubility: Practically insoluble in water and ether R; freely soluble in dimethylformamide R; slightly soluble in ethanol (~750 g/l) TS. Category: Antihypertensive. Storage: Diazoxide should be kept in a well-closed container. Definition: Diazoxide contains not less than 98.0% and not more than 101.0% of C8H7ClN2O2S, calculated with reference to thedried substance.
INN
1294
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
ECHA (EC/EINECS)
206-668-1
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
MESH
D003981
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
DRUG BANK
DB01119
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
RXCUI
3327
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY RxNorm
RS_ITEM_NUM
1186000
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
DRUG CENTRAL
854
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
DAILYMED
O5CB12L4FN
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
SMS_ID
100000092606
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
CAS
364-98-7
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
PUBCHEM
3019
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
IUPHAR
2409
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
ChEMBL
CHEMBL181
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
WIKIPEDIA
DIAZOXIDE
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
NSC
64198
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
EVMPD
SUB07071MIG
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
CHEBI
4495
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
NCI_THESAURUS
C428
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
NSC
76130
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
FDA UNII
O5CB12L4FN
Created by admin on Fri Dec 15 15:12:49 UTC 2023 , Edited by admin on Fri Dec 15 15:12:49 UTC 2023
PRIMARY
Related Record Type Details
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
CARBONIC ANHYDRASE 1
TARGET -> INHIBITOR
CARBONIC ANHYDRASE 2
TARGET -> INHIBITOR
Related Record Type Details
Structure of DIAZOXIDE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966